Department of Biology
Neuroprotective effects of astragaloside IV in 6-hydroxydopamine-treated primary nigral cell culture
Parkinson's disease (PD) is caused by a progressive degeneration of dopaminergic neurons in the substantia nigra. Oxidative stress and neural degeneration are suggested to be involved in the pathogenesis of Parkinson's disease. In the present study, Astragaloside IV (AS-IV) extracted from the dried root of Astragalus membranaceus, a well-known Chinese medicine used for the treatment of neurodegenerative diseases, was investigated for its capacity to protect dopaminergic neurons in experimental Parkinson's disease. By examining the effect of AS-IV on 6-hydroxydopamine (6-OHDA)-induced loss of dopaminergic neurons in primary nigral culture, we found that AS-IV pretreatment significantly and dose-dependently attenuated 6-OHDA-induced loss of dopaminergic neurons. Neuronal fiber length studies showed that massive neuronal cell death with degenerated neurons was observed in those cultures incubated with 6-OHDA, whereas in AS-IV co-treatments most dopaminergic neurons were seen to be intact and sprouting. In flow cytometric analysis, AS-IV resulted in a marked and dose-dependent rescue in tyrosine hydrolase (TH)-immunopositive cells from 6-OHDA-induced degeneration of dopaminergic neurons. Double immunofluorescence revealed that AS-IV treatment alone at concentrations of 100 and 200 μM increased the level of TH and NOS (nitrite oxide synthase) immunoreactivities; however, the protective effect of AS-IV on TH and NOS immunopositive cells in 6-OHDA treated nigral cell cultures was only seen at a concentration of 100 μM. These findings show that AS-IV can protect dopaminergic neurons against 6-OHDA-induced degeneration. Besides the neuroprotective effect, AS-IV alone promoted neurite outgrowth and increased TH and NOS immunoreactive of dopaminergic neurons. The neuroprotective and neurosprouting effects of AS-IV are specific for dopaminergic neurons and it has therapeutic potential in the treatment of PD. © 2009 Elsevier Ltd. All rights reserved.
6-Hydroxydopamine, Astragaloside IV, Nigral primary cell cultures, Nitric oxide synthase, Parkinson's disease, Tyrosine hydroxylase
Source Publication Title
2009国际分子神经退行性疾病大会 = 2009 International Conference on molecular Neurodegeneration
Chan, Wing-Sai, Siva Sundara Kumar Durairajan, Jia-Hon Lu, Yan Wang, Li-Xia Xie, Wan-Fung Kum, Irene Koo, Kin Lam Yung, and Min Li. "Neuroprotective effects of astragaloside IV in 6-hydroxydopamine-treated primary nigral cell culture." 2009国际分子神经退行性疾病大会 = 2009 International Conference on molecular Neurodegeneration (2009).